Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Clinical Breast Cancer|July 5, 2021
Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer TreatmentMaria Eleni Hatzipanagiotou, Deborah Huber, Valeria Gerthofer, et al.
Breast Cancer Research and Treatment|November 28, 2018
G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifenTanja Ignatov, Maria Claus, Norbert Nass, et al.
Cancers|May 14, 2022
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor MiceChristina Bruss, Kerstin Kellner, Olaf Ortmann, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 8, 2006
Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroidsJuergen M Weiss, Stephan J König, Stephan Polack, et al.
Journal of Molecular Endocrinology|February 13, 2007
Estradiol differentially modulates the exocytotic proteins SNAP-25 and munc-18 in pituitary gonadotrophsJürgen M Weiss, Heike Hüller, Stephan Polack, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2022
Guideline concordant therapy improves survival in high-grade endometrial cancer patientsSophia Scharl, Tim Sprötge, Michael Gerken, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2021
Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient carePatricia Lindberg-Scharf, Brunhilde Steinger, Michael Koller, et al.
Scientific Reports|September 3, 2020
Compared DNA and RNA quality of breast cancer biobanking samples after long-term storage protocols in - 80 °C and liquid nitrogenMaximilian Babel, Andreas Mamilos, Stephan Seitz, et al.
Archives of Gynecology and Obstetrics|October 25, 2022
Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgeryMiriam Fernández-Pacheco, Michael Gerken, Olaf Ortmann, et al.
Pageof 19